New antibiotic discovery, novel screens, novel targets and impact of microbial genomics

被引:44
作者
Allsop, AE [1 ]
机构
[1] Zeneca Pharmaceut, Canc & Infect Res Dept, Macclesfield SK10 4TG, Cheshire, England
关键词
D O I
10.1016/S1369-5274(98)80085-4
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The clinical need for new classes of antibiotic continues to grow as drug resistance erodes the efficacy of current therapies. Historically, most antibiotics were discovered by random screening campaigns, but over the past 20 years, this strategy has largely failed to deliver a sufficient range of chemical diversity to keep pace with changing clinical profiles. A more rational approach to drug hunting has been greatly potentiated by the availability of bacterial genomic information. The rapid progress in sequencing and analysis of these small, prokaryotic genomes has enabled the concomitant development of powerful new technologies that are already enhancing the potential utility of genomic information. The future promises versatile and precise tools to understand what makes a successful antibiotic and moreover the means to identify and evaluate novel classes of drug.
引用
收藏
页码:530 / 534
页数:5
相关论文
共 45 条
[11]   BACTERIAL GENOMES - A TIGR IN THE TANK [J].
DEVINE, KM ;
WOLFE, K .
TRENDS IN GENETICS, 1995, 11 (11) :429-431
[12]   The yeast genome project: What did we learn? [J].
Dujon, B .
TRENDS IN GENETICS, 1996, 12 (07) :263-270
[13]  
EGERTON M, 1998, GENOMICS COMMERCIAL, P133
[14]  
Falkow S, 1997, ASM NEWS, V63, P359
[15]   Common themes in microbial pathogenicity revisited [J].
Finlay, BB ;
Falkow, S .
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 1997, 61 (02) :136-+
[16]   Host-microbe interactions: bacteria - The new age of bacterial infectious diseases - Editorial overview [J].
Finlay, BB ;
Sansonetti, P .
CURRENT OPINION IN MICROBIOLOGY, 1998, 1 (01) :9-11
[17]   Toward a functional analysis of the yeast genome through exhaustive two-hybrid screens [J].
FromontRacine, M ;
Rain, JC ;
Legrain, P .
NATURE GENETICS, 1997, 16 (03) :277-282
[18]   Drug therapy - Antimicrobial-drug resistance [J].
Gold, HS ;
Moellering, RC .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (19) :1445-1453
[19]  
Gray C P, 1998, Expert Opin Investig Drugs, V7, P145, DOI 10.1517/13543784.7.2.145
[20]   Dissecting the biology of a pathogen during infection [J].
Heithoff, DM ;
Conner, CP ;
Mahan, MJ .
TRENDS IN MICROBIOLOGY, 1997, 5 (12) :509-513